Muscular Dystrophy
What is Muscular Dystrophy?
Muscular dystrophy is a group of genetic diseases that cause progressive muscle weakness and loss of muscle mass. These conditions happen when abnormal genes interfere with the production of proteins needed to build and maintain healthy muscles. Over time, muscle fibers break down and are replaced with fat and scar tissue.
There are more than 30 types of muscular dystrophy. Each type varies in age of onset, severity, and which muscle groups are affected first. Duchenne muscular dystrophy is the most common form in children, while myotonic dystrophy is the most common adult form. Some types progress slowly and cause minimal disability, while others advance quickly and lead to significant loss of mobility.
While muscular dystrophy is a genetic condition, understanding your muscle health through blood testing can help track disease progression and guide treatment decisions. Early detection and monitoring allow for better planning and quality of life management.
Symptoms
- Progressive muscle weakness, usually starting in the hips, thighs, and shoulders
- Frequent falls and difficulty rising from sitting or lying positions
- Waddling gait or walking on toes
- Enlarged calf muscles that are actually weaker, not stronger
- Difficulty running, jumping, or climbing stairs
- Muscle stiffness or cramping
- Difficulty swallowing or breathing in advanced stages
- Curved spine, known as scoliosis, as back muscles weaken
- Heart problems in some types of muscular dystrophy
- Learning disabilities in some cases
Symptoms typically appear in childhood for many types of muscular dystrophy, but some forms do not show signs until adolescence or adulthood. The rate of progression varies widely depending on the specific type.
Concerned about Muscular Dystrophy? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Muscular dystrophy is caused by mutations in genes responsible for producing proteins that protect muscle fibers. These genetic changes are usually inherited from one or both parents, though some cases occur from spontaneous mutations. The type of genetic mutation determines which type of muscular dystrophy develops. For example, Duchenne and Becker muscular dystrophy result from mutations in the dystrophin gene, which produces a protein that keeps muscle cells intact.
Risk factors include family history of muscular dystrophy and being male, as some types like Duchenne are X-linked and affect males almost exclusively. While you cannot prevent a genetic condition, knowing your family history helps with early detection and planning. Carriers of certain genes may not have symptoms themselves but can pass the condition to their children.
How it's diagnosed
Muscular dystrophy is diagnosed through a combination of clinical examination, family history, genetic testing, and blood tests. Blood tests measuring muscle enzymes are often the first step. When muscle cells break down, they release enzymes into the bloodstream. Elevated levels of creatine kinase, aldolase, and lactate dehydrogenase can indicate muscle damage consistent with muscular dystrophy.
Rite Aid offers blood testing that measures these key muscle enzymes as an add-on to our flagship health panel. Testing through our network of Quest Diagnostics locations makes monitoring muscle health accessible and convenient. If blood tests show abnormal results, your doctor may recommend genetic testing, muscle biopsy, or electromyography to confirm the specific type of muscular dystrophy and guide treatment planning.
Treatment options
- Physical therapy to maintain muscle strength and flexibility for as long as possible
- Occupational therapy to learn adaptive techniques for daily activities
- Corticosteroid medications like prednisone to slow muscle degeneration
- Heart medications if the condition affects cardiac muscle
- Breathing support devices as respiratory muscles weaken
- Mobility aids such as canes, walkers, or wheelchairs as needed
- Surgery to correct scoliosis or release tight tendons
- Gene therapy and other emerging treatments for specific types
- Regular monitoring of heart and lung function
- Nutritional support to maintain healthy weight and prevent obesity
Need testing for Muscular Dystrophy? Add it to your panel.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
The main differences are age of onset, rate of progression, and which muscle groups are affected. Duchenne muscular dystrophy appears in early childhood and progresses rapidly, while Becker muscular dystrophy has similar symptoms but starts later and progresses more slowly. Myotonic dystrophy affects adults and causes muscle stiffness along with weakness. Each type results from mutations in different genes that produce specific muscle proteins.
Blood tests cannot diagnose muscular dystrophy on their own, but they provide important clues. Elevated muscle enzymes like creatine kinase, aldolase, and lactate dehydrogenase indicate muscle damage. If these levels are high, doctors typically order genetic testing or muscle biopsy to confirm the diagnosis and identify the specific type. Regular blood testing also helps monitor disease progression over time.
Most cases of muscular dystrophy are inherited from one or both parents who carry the gene mutation. However, about one third of cases result from spontaneous genetic mutations with no family history. Once a new mutation occurs, it can be passed to future generations. Genetic counseling can help families understand their risk and inheritance patterns.
Creatine kinase is an enzyme found primarily in muscle tissue. When muscle cells are damaged or breaking down, creatine kinase leaks into the bloodstream. In muscular dystrophy, levels can be 10 to 100 times higher than normal. Regular monitoring of creatine kinase helps track disease activity and treatment response.
Gentle, low-impact exercise guided by a physical therapist can help maintain muscle function and prevent contractures. Swimming and stretching are often beneficial. However, intense or exhausting exercise can accelerate muscle damage in some types of muscular dystrophy. Working with specialists to create an individualized exercise plan is essential for balancing activity with muscle preservation.
Progression rates vary dramatically by type. Duchenne muscular dystrophy progresses rapidly, with most children needing wheelchairs by age 12. Becker muscular dystrophy progresses more slowly over decades. Limb-girdle and other types have variable courses. Regular monitoring through physical exams and blood tests helps track individual progression and adjust care plans.
Aldolase is an enzyme involved in breaking down sugar for energy in muscle cells. When muscles are damaged, aldolase is released into the blood. Elevated aldolase levels suggest muscle injury or disease, including muscular dystrophy. While not as commonly measured as creatine kinase, aldolase provides additional confirmation of muscle damage when levels are high.
Yes, women can be affected by muscular dystrophy. Some types like myotonic dystrophy and limb-girdle muscular dystrophy affect males and females equally. Women who carry genes for X-linked types like Duchenne may have mild symptoms or be asymptomatic carriers. Female carriers can still pass the condition to their sons and should consider genetic counseling.
Currently, there is no cure for muscular dystrophy. However, treatments can slow progression, manage symptoms, and improve quality of life. Corticosteroids have been shown to preserve muscle strength for several years. New gene therapies and exon-skipping drugs show promise for specific genetic mutations. Research continues to develop disease-modifying treatments.
Testing frequency depends on the type of muscular dystrophy and stage of disease. During initial diagnosis, blood tests may be done every few months to establish patterns. Once stable, annual or biannual monitoring of muscle enzymes helps track progression. Your care team will recommend a testing schedule based on your individual needs and treatment plan.